Fund profile
Tickers
WDNA
Fund manager
Total assets
$2.80 mm
Liabilities
$102.71 k
Net assets
$2.70 mm
Number of holdings
94.00
WDNA stock data
94 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
State Street Navigator Securities Lending Government Money Market Portfolio | 101.71 k | 101.71 k shares | 3.77 | Short-term investment vehicle | Long | USA |
TWST Twist Bioscience Corp | 88.69 k | 2.41 k shares | 3.29 | Common equity | Long | USA |
BBIO BridgeBio Pharma Inc | 63.34 k | 1.57 k shares | 2.35 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 59.03 k | 640.00 shares | 2.19 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics Inc | 52.76 k | 6.49 k shares | 1.96 | Common equity | Long | USA |
EDIT Editas Medicine Inc | 43.03 k | 4.25 k shares | 1.60 | Common equity | Long | USA |
FOLD Amicus Therapeutics Inc | 42.47 k | 2.99 k shares | 1.57 | Common equity | Long | USA |
DNA Ginkgo Bioworks Holdings Inc - Ordinary Shares | 41.42 k | 24.51 k shares | 1.54 | Common equity | Long | USA |
FATE Fate Therapeutics Inc | 40.95 k | 10.95 k shares | 1.52 | Common equity | Long | USA |
LLY Lilly(Eli) & Co | 40.22 k | 69.00 shares | 1.49 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 38.78 k | 811.00 shares | 1.44 | Common equity | Long | USA |
VCYT Veracyte Inc | 38.54 k | 1.40 k shares | 1.43 | Common equity | Long | USA |
NTRA Natera Inc | 37.90 k | 605.00 shares | 1.41 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 37.89 k | 749.00 shares | 1.40 | Common equity | Long | USA |
SDGR Schrodinger Inc | 37.70 k | 1.05 k shares | 1.40 | Common equity | Long | USA |
GERN Geron Corp. | 37.32 k | 17.69 k shares | 1.38 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 37.27 k | 1.18 k shares | 1.38 | Common equity | Long | USA |
CRISPR Therapeutics AG
|
37.25 k | 595.00 shares | 1.38 | Common equity | Long | Switzerland |
VCEL Vericel Corp | 37.03 k | 1.04 k shares | 1.37 | Common equity | Long | USA |
Evotec SE
|
36.34 k | 1.55 k shares | 1.35 | Common equity | Long | Germany |
MRTX Mirati Therapeutics Inc | 34.13 k | 581.00 shares | 1.27 | Common equity | Long | USA |
EXAS Exact Sciences Corp. | 33.88 k | 458.00 shares | 1.26 | Common equity | Long | USA |
CRBU Caribou Biosciences Inc | 33.70 k | 5.88 k shares | 1.25 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 33.36 k | 82.00 shares | 1.24 | Common equity | Long | USA |
ZTS Zoetis Inc - Ordinary Shares | 32.96 k | 167.00 shares | 1.22 | Common equity | Long | USA |
TXG 10x Genomics Inc - Ordinary Shares | 32.23 k | 576.00 shares | 1.20 | Common equity | Long | USA |
Chr Hansen Holding A/S
|
32.22 k | 384.00 shares | 1.19 | Common equity | Long | Denmark |
GEVO Gevo Inc | 32.00 k | 27.58 k shares | 1.19 | Common equity | Long | USA |
AMGN AMGEN Inc. | 31.97 k | 111.00 shares | 1.19 | Common equity | Long | USA |
Novartis AG
|
31.97 k | 317.00 shares | 1.19 | Common equity | Long | Switzerland |
DHR Danaher Corp. | 31.92 k | 138.00 shares | 1.18 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals Inc | 31.60 k | 1.42 k shares | 1.17 | Common equity | Long | USA |
DD DuPont de Nemours Inc | 31.54 k | 410.00 shares | 1.17 | Common equity | Long | USA |
RGEN Repligen Corp. | 31.47 k | 175.00 shares | 1.17 | Common equity | Long | USA |
Novozymes A/S
|
31.45 k | 572.00 shares | 1.17 | Common equity | Long | Denmark |
REGN Regeneron Pharmaceuticals, Inc. | 30.74 k | 35.00 shares | 1.14 | Common equity | Long | USA |
VERV Verve Therapeutics Inc | 30.64 k | 2.20 k shares | 1.14 | Common equity | Long | USA |
NEO Neogenomics Inc. | 30.32 k | 1.87 k shares | 1.12 | Common equity | Long | USA |
A Agilent Technologies Inc. | 29.61 k | 213.00 shares | 1.10 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals Inc. | 29.56 k | 966.00 shares | 1.10 | Common equity | Long | USA |
DOW Dow Inc | 29.39 k | 536.00 shares | 1.09 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 29.31 k | 304.00 shares | 1.09 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 29.09 k | 152.00 shares | 1.08 | Common equity | Long | USA |
DAR Darling Ingredients Inc | 29.06 k | 583.00 shares | 1.08 | Common equity | Long | USA |
QIAGEN NV
|
28.79 k | 663.00 shares | 1.07 | Common equity | Long | Netherlands |
LH Laboratory Corp. Of America Holdings | 28.64 k | 126.00 shares | 1.06 | Common equity | Long | USA |
RGNX Regenxbio Inc | 28.36 k | 1.58 k shares | 1.05 | Common equity | Long | USA |
TSN Tyson Foods, Inc. - Ordinary Shares | 27.90 k | 519.00 shares | 1.03 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 27.73 k | 1.45 k shares | 1.03 | Common equity | Long | USA |
CTLT Catalent Inc. | 27.72 k | 617.00 shares | 1.03 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 27.60 k | 52.00 shares | 1.02 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 27.46 k | 339.00 shares | 1.02 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc | 27.44 k | 1.01 k shares | 1.02 | Common equity | Long | USA |
MRK Merck & Co Inc | 27.36 k | 251.00 shares | 1.01 | Common equity | Long | USA |
JNJ Johnson & Johnson | 27.27 k | 174.00 shares | 1.01 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 27.27 k | 124.00 shares | 1.01 | Common equity | Long | USA |
AstraZeneca PLC
|
26.87 k | 399.00 shares | 1.00 | Common equity | Long | UK |
CFRXQ CONTRAFECT Corp | 26.73 k | 2.73 k shares | 0.99 | Common equity | Long | USA |
Syensqo SA
|
26.66 k | 256.00 shares | 0.99 | Common equity | Long | Belgium |
ADM Archer Daniels Midland Co. | 26.58 k | 368.00 shares | 0.99 | Common equity | Long | USA |
TECH Bio-Techne Corp | 26.54 k | 344.00 shares | 0.98 | Common equity | Long | USA |
GPRE Green Plains Inc | 26.51 k | 1.05 k shares | 0.98 | Common equity | Long | USA |
BIIB Biogen Inc | 25.88 k | 100.00 shares | 0.96 | Common equity | Long | USA |
Takeda Pharmaceutical Co Ltd
|
25.65 k | 892.00 shares | 0.95 | Common equity | Long | Japan |
BNTX BioNTech SE | 24.80 k | 235.00 shares | 0.92 | Common equity | Long | Germany |
NTLA Intellia Therapeutics Inc | 24.61 k | 807.00 shares | 0.91 | Common equity | Long | USA |
Genmab A/S
|
24.58 k | 772.00 shares | 0.91 | Common equity | Long | Denmark |
RVTY Revvity Inc. | 24.38 k | 223.00 shares | 0.90 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 23.72 k | 246.00 shares | 0.88 | Common equity | Long | USA |
CTVA Corteva Inc | 23.38 k | 488.00 shares | 0.87 | Common equity | Long | USA |
NTR Nutrien Ltd | 23.04 k | 409.00 shares | 0.85 | Common equity | Long | Canada |
Vitrolife AB
|
21.02 k | 1.09 k shares | 0.78 | Common equity | Long | Sweden |
PFE Pfizer Inc. | 21.02 k | 730.00 shares | 0.78 | Common equity | Long | USA |
BIO Bio-Rad Laboratories Inc. - Ordinary Shares | 20.34 k | 63.00 shares | 0.75 | Common equity | Long | USA |
Nufarm Ltd
|
20.11 k | 5.65 k shares | 0.75 | Common equity | Long | Australia |
BYND Beyond Meat Inc | 19.40 k | 2.18 k shares | 0.72 | Common equity | Long | USA |
MRNA Moderna Inc | 19.29 k | 194.00 shares | 0.72 | Common equity | Long | USA |
uniQure NV
|
19.21 k | 2.84 k shares | 0.71 | Common equity | Long | Netherlands |
FMC FMC Corp. | 18.92 k | 300.00 shares | 0.70 | Common equity | Long | USA |
ILMN Illumina Inc | 18.80 k | 135.00 shares | 0.70 | Common equity | Long | USA |
Verbio Vereinigte Bioenergie AG
|
18.68 k | 566.00 shares | 0.69 | Common equity | Long | Germany |
ALLO Allogene Therapeutics Inc | 18.52 k | 5.77 k shares | 0.69 | Common equity | Long | USA |
TSVT 2seventy bio Inc | 17.89 k | 4.19 k shares | 0.66 | Common equity | Long | USA |
AGEN Agenus Inc | 17.80 k | 21.50 k shares | 0.66 | Common equity | Long | USA |
Bayer AG
|
16.87 k | 454.00 shares | 0.63 | Common equity | Long | Germany |
Genus PLC
|
16.54 k | 598.00 shares | 0.61 | Common equity | Long | UK |
ORGN Origin Materials Inc | 15.05 k | 17.99 k shares | 0.56 | Common equity | Long | USA |
CureVac NV
|
13.73 k | 3.26 k shares | 0.51 | Common equity | Long | Netherlands |
Oxford Nanopore Technologies PLC
|
13.26 k | 5.00 k shares | 0.49 | Common equity | Long | UK |
STOK Stoke Therapeutics Inc | 12.46 k | 2.37 k shares | 0.46 | Common equity | Long | USA |
Takara Bio Inc
|
12.43 k | 1.40 k shares | 0.46 | Common equity | Long | Japan |
PGEN Precigen Inc | 9.10 k | 6.79 k shares | 0.34 | Common equity | Long | USA |
Lenzing AG
|
8.21 k | 209.00 shares | 0.30 | Common equity | Long | Austria |
Solvay SA
|
7.75 k | 253.00 shares | 0.29 | Common equity | Long | Belgium |